1. Home
  2. TNGX vs BNED Comparison

TNGX vs BNED Comparison

Compare TNGX & BNED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • BNED
  • Stock Information
  • Founded
  • TNGX 2014
  • BNED 1965
  • Country
  • TNGX United States
  • BNED United States
  • Employees
  • TNGX N/A
  • BNED N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • BNED Other Specialty Stores
  • Sector
  • TNGX Health Care
  • BNED Consumer Discretionary
  • Exchange
  • TNGX Nasdaq
  • BNED Nasdaq
  • Market Cap
  • TNGX 317.4M
  • BNED 335.1M
  • IPO Year
  • TNGX N/A
  • BNED N/A
  • Fundamental
  • Price
  • TNGX $1.67
  • BNED $10.49
  • Analyst Decision
  • TNGX Strong Buy
  • BNED Hold
  • Analyst Count
  • TNGX 7
  • BNED 1
  • Target Price
  • TNGX $12.33
  • BNED N/A
  • AVG Volume (30 Days)
  • TNGX 853.8K
  • BNED 410.7K
  • Earning Date
  • TNGX 05-07-2025
  • BNED 03-10-2025
  • Dividend Yield
  • TNGX N/A
  • BNED N/A
  • EPS Growth
  • TNGX N/A
  • BNED N/A
  • EPS
  • TNGX N/A
  • BNED N/A
  • Revenue
  • TNGX $42,069,000.00
  • BNED $1,567,800,000.00
  • Revenue This Year
  • TNGX N/A
  • BNED $2.74
  • Revenue Next Year
  • TNGX N/A
  • BNED N/A
  • P/E Ratio
  • TNGX N/A
  • BNED N/A
  • Revenue Growth
  • TNGX 15.17
  • BNED N/A
  • 52 Week Low
  • TNGX $1.60
  • BNED $6.05
  • 52 Week High
  • TNGX $12.02
  • BNED $135.00
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 32.02
  • BNED 59.14
  • Support Level
  • TNGX $1.65
  • BNED $9.55
  • Resistance Level
  • TNGX $1.81
  • BNED $10.75
  • Average True Range (ATR)
  • TNGX 0.16
  • BNED 0.63
  • MACD
  • TNGX 0.01
  • BNED 0.21
  • Stochastic Oscillator
  • TNGX 8.57
  • BNED 93.63

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is an operator of bookstores in college and university campuses across the United States. The company is also engaged in providing digital education services. It operates in three reportable segments that include Retail offers existing and prospective clients the flexibility of physical, virtual, or custom store solutions, and wholesale is comprised of the wholesale and virtual retail fulfillment, and support operations of the MBS subsidiary, also Corporate Services represent unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources. It earns majority of the revenue from Retail segment.

Share on Social Networks: